Match!
Marco Infante
University of Miami
Vitamin D and neurologyEndocrinologyvitamin D deficiencyDiabetes mellitusMedicine
6Publications
1H-index
2Citations
What is this?
Publications 10
Newest
#1Marco Infante (UM: University of Miami)H-Index: 1
#2Andrea FabbriH-Index: 5
Source
#1Marco InfanteH-Index: 2
#1Marco Infante (UM: University of Miami)H-Index: 1
Last. Andrea FabbriH-Index: 5
view all 3 authors...
Source
#1David A. Baidal (UM: University of Miami)H-Index: 24
#2Marco Infante (University of Rome Tor Vergata)H-Index: 1
Last. Rodolfo Alejandro (UM: University of Miami)H-Index: 48
view all 11 authors...
Abstract Islet transplantation (ITx) is a cellular therapy that has demonstrated efficacy in improving glycemic control and abolishing hypoglycemia in patients affected by type 1 diabetes complicated by hypoglycemia unawareness and episodes of severe hypoglycemia. Although the intrahepatic site is the only clinical site that has shown long-term islet allograft engraftment with achievement of insulin independence, it remains far from being an ideal transplantation site. In this chapter, we have d...
Source
#1Marco Infante (University of Rome Tor Vergata)H-Index: 1
#2Nathalia Padilla (UM: University of Miami)H-Index: 2
Last. Rodolfo Alejandro (UM: University of Miami)H-Index: 48
view all 7 authors...
Abstract Liver cirrhosis is an increasing global public health burden, representing a relevant cause of morbidity and mortality worldwide. Hepatogenous diabetes (HD) is defined as an acquired condition of impaired glucose regulation due to the loss of liver function caused by cirrhosis, which exacerbates the poor long-term prognosis of cirrhotic patients. Nevertheless, HD has not yet been considered as a distinct clinical entity separated from classical type 2 diabetes mellitus. However, prompt ...
Source
#1Marco Infante (University of Rome Tor Vergata)H-Index: 1
#2Camillo RicordiH-Index: 83
Last. AndreaFabbri (University of Rome Tor Vergata)H-Index: 41
view all 12 authors...
Type 1 diabetes (T1D) is a chronic autoimmune disease leading to immune-mediated destruction of pancreatic beta cells, resulting in the need for insulin therapy. The incidence of T1D is increasing worldwide, thus prompting researchers to investigate novel immunomodulatory strategies to halt autoimmunity and modify disease progression. T1D is considered as a multifactorial disease, in which genetic predisposition and environmental factors interact to promote the triggering of autoimmune responses...
3 CitationsSource
#1Andrea M. ArmaniH-Index: 20
#2Marco Infante (UM: University of Miami)H-Index: 1
Last. Massimiliano Caprio (OU: Open University)H-Index: 25
view all 4 authors...
Source
#1Marco Infante (UM: University of Miami)H-Index: 1
#2Andrea FabbriH-Index: 5
Source
#1Marco Infante (UM: University of Miami)H-Index: 1
#2Andrea FabbriH-Index: 5
Source
#1Marco Infante (University of Rome Tor Vergata)H-Index: 1
#2Camillo Ricordi (UM: University of Miami)H-Index: 83
Last. AndreaFabbri (University of Rome Tor Vergata)H-Index: 41
view all 8 authors...
2 CitationsSource
#1Camillo RicordiH-Index: 83
view all 7 authors...
Chronic inflammation has been linked to the progression of type 1 diabetes (T1D). Supplementation with vitamin D and omega-3 fatty acids, which have anti-inflammatory properties, may slow or stop the progression of T1D. A field study is underway to assess the relationship between these nutrients and T1D progression among auto-antibody positive individuals who have not been diagnosed with T1D. The T1D Prevention Field Study is currently recruiting participants to complete online health surveys an...
Source
1